Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|October 31, 2003
Dopamine agonists in Parkinson's diseaseRon Tintner, Joseph JankovicCurrent Opinion in Neurology|August 2, 2002
Treatment options for Parkinson's diseaseRon Tintner, Joseph JankovicThe Lancet. Neurology|June 21, 2005
Striatal deformities of the hand and foot in Parkinson's diseaseRamsey Ashour, Ron Tintner, Joseph JankovicArchives of Neurology|August 10, 2005
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson DiseaseRon Tintner, Prasad Manian, Polly Gauthier, et al.Clinical Neuropharmacology|December 7, 2002
Tetrabenazine treatment for Huntington's disease-associated choreaWilliam G Ondo, Ron Tintner, Madhavi Thomas, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2005
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's diseaseWilliam G Ondo, Ron Tintner, Kevin Dat Voung, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic stormPuneet Opal, Ron Tintner, Joseph Jankovic, et al.Brain : a Journal of Neurology|August 8, 2006
Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scalesRodger J Elble, Seth L Pullman, Joseph Y Matsumoto, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 4, 2012
Reliability of a new scale for essential tremorRodger Elble, Cynthia Comella, Stanley Fahn, et al.Drug Safety|May 9, 2003
Benefits and risks of pharmacological treatments for essential tremorKelly E Lyons, Rajesh Pahwa, Cynthia L Comella, et al.Pageof 1